Pricing

Trishula Therapeutics

‌

Trishula Therapeutics is a clinical-stage cancer immunotherapy company developing TTX-030, a first-in-class anti-CD39 antibody.

Industries

Biotechnology

Headquarters

South San Francisco, United States

Employees

1-10

Links

Org chart

Anil Singhal

President & CEO

Collapse

Alan Luk

VP, CMC

Siddhartha Mitra

Chief Medical Officer

Shawnalea Frazier

Board Of Directors (observer)

Board & advisors

Director

Director

Director

Director

Director

Teams

Leadership Team

2 people · 0 jobs

Clinical Operations and Data Management

3 people · 0 jobs

Offices

HQ
2 people · 0 jobs

Similar companies

Gilead Sciences

159 followers

Regeneron

130 followers

Illumina

79 followers

Agilent Technologies

81 followers

Verily Life Sciences

45 followers

Alexion Pharmaceuticals

45 followers

GRAIL

28 followers

Cytiva

16 followers

PerkinElmer

12 followers

Editas Medicine

5 followers

Organogenesis

5 followers

Explore companies